Skip to main content
TipRanks
Go Ultimate75% OFF

Matinas BioPharma (MTNB) Q3 2018 Earnings Report

1,546 Followers

MTNB Q3 2018 EPS Results

Actual EPS
-$0.03
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.04

MTNB Q3 2018 Revenue Results

Actual Revenue
$0
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2018
Date
11/12/2018
Time
TBA
Conference Call
Monday, November 12, 2018

Q3 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

MTNB Earnings History

MTNB earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 07, 20262026 (Q1)―-0.30-0.337.98% (+0.03)
Aug 19, 20252025 (Q2)―-1.03-1-3.10% (-0.03)
May 08, 20252025 (Q1)―-0.33-1.578.27% (+1.17)
Mar 18, 20252024 (Q4)-0.78-1.66-1-65.80% (-0.66)
Nov 06, 20242024 (Q3)-1.05-0.85-1.543.33% (+0.65)
Aug 14, 20242024 (Q2)-18.75-15.00-22.533.33% (+7.50)
May 09, 20242024 (Q1)-22.50-22.50-22.50.00% (+0.00)
Mar 27, 20242023 (Q4)-22.50-15.00-150.00% (+0.00)
Nov 08, 20232023 (Q3)-21.79-22.50-22.50.00% (+0.00)
Aug 09, 20232023 (Q2)-22.76-22.50-22.50.00% (+0.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed